Hongxia Wang, Doctor
Fudan University · Shanghai General Hospital, Fudan University Shanghai Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hongxia Wang, Doctor as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:51 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06684327 · Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced TumorsFudan University · recruiting · Paget Disease, Extramammary, Rhabdomyosarcoma, Testicular Cancer · study director
- Ph2NCT06683846 · Ivonescimab in the Treatment of Multiple Advanced TumorsFudan University · recruiting · Pheochromocytoma/Paraganglioma, Rhabdomyosarcoma, Paget Disease, Extramammary · principal investigator
- Early Ph1NCT05831033 · Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid TumorsShanghai General Hospital, Shanghai Jiao Tong University School of Medicine · recruiting · Solid Tumor · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in rhabdomyosarcoma.